News | July 17, 2025
Corona Remedies acquires 7 brands from Bayer's pharma division in India
This marks the fourth acquisition by Corona Remedies from multinational corporations
This marks the fourth acquisition by Corona Remedies from multinational corporations
Celecoxib is a nonsteroidal anti-inflammatory drug
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
It is intended for contrast enhancement in MRI scans
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Subscribe To Our Newsletter & Stay Updated
